Reply to "Switching the scope from 'how to identify cancer survivors' to 'who is participating in cancer survivorship research': A proposal for a new focus"

Affiliations

¹ Division of Clinical and Health Services Research, National Institute on Minority Health and Health Disparities, Bethesda, Maryland.
² Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
³ Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
⁴ Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
⁵ National Coalition for Cancer Survivorship, Silver Spring, Maryland.
⁶ Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
⁷ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Free article

Comment

Michelle Doose et al. Cancer. 2022.

Free article

. 2022 May 15;128(10):2038-2039.

doi: 10.1002/cncr.34129. Epub 2022 Feb 8.

¹ Division of Clinical and Health Services Research, National Institute on Minority Health and Health Disparities, Bethesda, Maryland.
² Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
³ Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
⁴ Department of Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
⁵ National Coalition for Cancer Survivorship, Silver Spring, Maryland.
⁶ Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
⁷ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Switching the scope from "how to identify cancer survivors" to "who is participating in cancer survivorship research": A proposal for a new focus.
van de Wal D, Janssen SHM, van der Meer DJ, Vlooswijk CCP, Roos DC, Bootsma TI, Fles R, Burgers VWG, Husson O. van de Wal D, et al. Cancer. 2022 May 15;128(10):2036-2037. doi: 10.1002/cncr.34130. Epub 2022 Feb 8. Cancer. 2022. PMID: 35132621 No abstract available.

1. Doose M, Mollica MA, Attai DJ, et al. Identifying and describing cancer survivors: implications for cancer survivorship research and clinical care. Cancer. 2022;128:383-390. doi:10.1002/cncr.33937
1. Plain language at NIH. National Institutes of Health. Accessed January 3, 2022. https://www.nih.gov/institutes-nih/nih-office-director/office-communicat...
1. Jung A, Kay SS, Robinson JL, Sheppard BB, Mayer DK. Large-scale North American cancer survivorship surveys: 2011-2019 update. J Cancer Surviv. Published online November 4, 2021. doi:10.1007/s11764-021-01111-w
1. Croyle RT, Sanchez JI, Doose M, Kennedy AE, Srinivasan S. Avoiding pro forma: a health equity-conscious approach to cancer control research. Am J Prev Med. Published online December 22, 2021. doi:10.1016/j.amepre.2021.09.021